CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 102 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,000 | -25.0% | 1,034 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | -33.3% | 1,034 | +106.8% | 0.00% | -100.0% |
| Q4 2020 | $6,000 | -88.5% | 500 | -85.9% | 0.00% | -75.0% |
| Q3 2018 | $52,000 | +36.8% | 3,545 | +54.8% | 0.00% | +33.3% |
| Q2 2018 | $38,000 | -77.6% | 2,290 | -65.3% | 0.00% | -81.2% |
| Q4 2017 | $170,000 | +23.2% | 6,608 | -18.7% | 0.02% | +14.3% |
| Q1 2017 | $138,000 | – | 8,131 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |